Status:
COMPLETED
Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
Lead Sponsor:
University of Tartu
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The treatment of differentiated thyroid cancer (DCT) includes surgery followed by radioiodine treatment. In the follow-up of patients it is necessary to induce TSH elevation to test for cancer recurre...
Detailed Description
The treatment of differentiated thyroid cancer (DCT) includes surgery followed by radioiodine treatment. In the follow-up of patients it is necessary to induce TSH elevation for the measurement of thy...
Eligibility Criteria
Inclusion
- Differentiated thyroid cancer
- treated by thyroidectomy and at least 1 ablation with 131-I \> 5 months ago
- TSH \< 4 imU/L
Exclusion
- Pregnancy
- Known metastasis
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01840332
Start Date
April 1 2013
End Date
February 1 2014
Last Update
March 14 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
East Tallinn Central Hospital
Tallinn, Estonia, 10138
2
Tartu University Hospital
Tartu, Estonia, 50406